Cardiac sarcoidosis.

Clin Chest Med

Division of Pulmonary and Critical Care Medicine, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, USA.

Published: September 2008

AI Article Synopsis

  • Sarcoidosis is a systemic disease generally associated with a good outlook, high chances of remission, and low death rates, but heart involvement can change this.
  • Common heart-related symptoms include irregular heartbeats, conduction issues, and signs of heart failure.
  • Treatment options involve immunosuppressants, permanent pacemakers for conduction issues, and defibrillators for those at risk of sudden cardiac death, with risk assessment being crucial for asymptomatic patients.

Article Abstract

Sarcoidosis is a systemic disease with a favorable prognosis, high remission rate, and low mortality. Cardiac involvement alters this prognosis. Clinical manifestations most commonly include arrhythmias, conduction abnormalities, and congestive heart failure. Treatment includes immunosuppressant therapy, permanent pacemakers in the setting of conduction abnormalities, and implantable cardioverter-defibrillators in patients at risk for sudden cardiac death. Risk stratification for sudden cardiac death is essential in otherwise asymptomatic patients who have suspected cardiac sarcoidosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccm.2008.03.005DOI Listing

Publication Analysis

Top Keywords

cardiac sarcoidosis
8
conduction abnormalities
8
sudden cardiac
8
cardiac death
8
cardiac
5
sarcoidosis sarcoidosis
4
sarcoidosis systemic
4
systemic disease
4
disease favorable
4
favorable prognosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!